1
|
Ghozy S, Liu M, Kobeissi H, Mortezaei A, Amoukhteh M, Abbas AS, Dmytriw AA, Kadirvel R, Rabinstein AA, Kallmes DF, Nasr D. Cardiac CT vs Echocardiography for Intracardiac Thrombus Detection in Ischemic Stroke: A Systematic Review and Meta-Analysis of 43 Studies. Neurology 2024; 103:e209771. [PMID: 39270155 DOI: 10.1212/wnl.0000000000209771] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 09/15/2024] Open
Abstract
BACKGROUND AND OBJECTIVES Ischemic stroke, a leading cause of mortality, necessitates understanding its mechanism for effective prevention. Echocardiography, especially transesophageal echocardiography (TEE), is the gold standard for detection of cardiac sources of stroke including left atrial thrombus, although its invasiveness, operator skill dependence, and limited availability in some centers prompt exploration of alternatives, such as cardiac CT (CCT). We conducted a systematic review and meta-analysis assessing the ability of CCT in the detection of intracardiac thrombus compared with echocardiography. METHODS We searched 4 databases up through September 8, 2023. Major search terms included a combination of the terms "echocardiograph," "CT," "TEE," "imaging," "stroke," "undetermined," and "cryptogenic." The current systematic literature review of the English language literature was reported in adherence to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses reporting guidelines. We assessed risk of bias using the QUADAS-2 tool and used random-effects meta-analysis to calculate different diagnostic metrics. RESULTS The meta-analysis investigating CCT vs echocardiography for intracardiac thrombus detection yielded a total of 43 studies of 9,552 patients. Risk-of-bias assessment revealed a predominantly low risk of bias in the flow and timing, index test, and patient selection domains and a predominantly unclear risk of bias in the reference standard domain. The analysis revealed an overall sensitivity of 98.38% (95% CI 89.2-99.78) and specificity of 96.0% (95% CI 92.55-97.88). Subgroup analyses demonstrated that delayed-phase, electrocardiogram-gated CCT had the highest sensitivity (100%; 95% CI 0-100) while early-phase, nongated CCT exhibited a sensitivity of 94.31% (95% CI 28.58-99.85). The diagnostic odds ratio was 98.59 (95% CI 44.05-220.69). Heterogeneity was observed, particularly in specificity and diagnostic odds ratio estimates. DISCUSSION CCT demonstrates high sensitivity, specificity, and diagnostic odds ratios in detecting intracardiac thrombus compared with traditional echocardiography. Limitations include the lack of randomized controlled studies, and other cardioembolic sources of stroke such as valvular disease, cardiac function, and aortic arch disease were not examined in our analysis. Large-scale studies are warranted to further evaluate CCT as a promising alternative for identifying intracardiac thrombus and other sources of cardioembolic stroke.
Collapse
Affiliation(s)
- Sherief Ghozy
- From the Departments of Radiology (S.G., H.K., A.M., M.A., D.F.K., R.K.), Neurologic Surgery (S.G., R.K.), and Neurology (M.L., A.A.R., D.N.), Mayo Clinic, Rochester, MN; Evidence-based Practice Center (A.S.A.), Kern Center for the Science of Healthcare Delivery, Mayo Clinic, Rochester, MN; Neuroendovascular Program (A.A.D.), Massachusetts General Hospital & Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Neurovascular Centre, Divisions of Therapeutic Neuroradiology & Neurosurgery (A.A.D.), St. Michael's Hospital, University of Toronto, ON, Canada
| | - Michael Liu
- From the Departments of Radiology (S.G., H.K., A.M., M.A., D.F.K., R.K.), Neurologic Surgery (S.G., R.K.), and Neurology (M.L., A.A.R., D.N.), Mayo Clinic, Rochester, MN; Evidence-based Practice Center (A.S.A.), Kern Center for the Science of Healthcare Delivery, Mayo Clinic, Rochester, MN; Neuroendovascular Program (A.A.D.), Massachusetts General Hospital & Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Neurovascular Centre, Divisions of Therapeutic Neuroradiology & Neurosurgery (A.A.D.), St. Michael's Hospital, University of Toronto, ON, Canada
| | - Hassan Kobeissi
- From the Departments of Radiology (S.G., H.K., A.M., M.A., D.F.K., R.K.), Neurologic Surgery (S.G., R.K.), and Neurology (M.L., A.A.R., D.N.), Mayo Clinic, Rochester, MN; Evidence-based Practice Center (A.S.A.), Kern Center for the Science of Healthcare Delivery, Mayo Clinic, Rochester, MN; Neuroendovascular Program (A.A.D.), Massachusetts General Hospital & Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Neurovascular Centre, Divisions of Therapeutic Neuroradiology & Neurosurgery (A.A.D.), St. Michael's Hospital, University of Toronto, ON, Canada
| | - Ali Mortezaei
- From the Departments of Radiology (S.G., H.K., A.M., M.A., D.F.K., R.K.), Neurologic Surgery (S.G., R.K.), and Neurology (M.L., A.A.R., D.N.), Mayo Clinic, Rochester, MN; Evidence-based Practice Center (A.S.A.), Kern Center for the Science of Healthcare Delivery, Mayo Clinic, Rochester, MN; Neuroendovascular Program (A.A.D.), Massachusetts General Hospital & Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Neurovascular Centre, Divisions of Therapeutic Neuroradiology & Neurosurgery (A.A.D.), St. Michael's Hospital, University of Toronto, ON, Canada
| | - Melika Amoukhteh
- From the Departments of Radiology (S.G., H.K., A.M., M.A., D.F.K., R.K.), Neurologic Surgery (S.G., R.K.), and Neurology (M.L., A.A.R., D.N.), Mayo Clinic, Rochester, MN; Evidence-based Practice Center (A.S.A.), Kern Center for the Science of Healthcare Delivery, Mayo Clinic, Rochester, MN; Neuroendovascular Program (A.A.D.), Massachusetts General Hospital & Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Neurovascular Centre, Divisions of Therapeutic Neuroradiology & Neurosurgery (A.A.D.), St. Michael's Hospital, University of Toronto, ON, Canada
| | - Alzhraa S Abbas
- From the Departments of Radiology (S.G., H.K., A.M., M.A., D.F.K., R.K.), Neurologic Surgery (S.G., R.K.), and Neurology (M.L., A.A.R., D.N.), Mayo Clinic, Rochester, MN; Evidence-based Practice Center (A.S.A.), Kern Center for the Science of Healthcare Delivery, Mayo Clinic, Rochester, MN; Neuroendovascular Program (A.A.D.), Massachusetts General Hospital & Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Neurovascular Centre, Divisions of Therapeutic Neuroradiology & Neurosurgery (A.A.D.), St. Michael's Hospital, University of Toronto, ON, Canada
| | - Adam A Dmytriw
- From the Departments of Radiology (S.G., H.K., A.M., M.A., D.F.K., R.K.), Neurologic Surgery (S.G., R.K.), and Neurology (M.L., A.A.R., D.N.), Mayo Clinic, Rochester, MN; Evidence-based Practice Center (A.S.A.), Kern Center for the Science of Healthcare Delivery, Mayo Clinic, Rochester, MN; Neuroendovascular Program (A.A.D.), Massachusetts General Hospital & Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Neurovascular Centre, Divisions of Therapeutic Neuroradiology & Neurosurgery (A.A.D.), St. Michael's Hospital, University of Toronto, ON, Canada
| | - Ramanathan Kadirvel
- From the Departments of Radiology (S.G., H.K., A.M., M.A., D.F.K., R.K.), Neurologic Surgery (S.G., R.K.), and Neurology (M.L., A.A.R., D.N.), Mayo Clinic, Rochester, MN; Evidence-based Practice Center (A.S.A.), Kern Center for the Science of Healthcare Delivery, Mayo Clinic, Rochester, MN; Neuroendovascular Program (A.A.D.), Massachusetts General Hospital & Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Neurovascular Centre, Divisions of Therapeutic Neuroradiology & Neurosurgery (A.A.D.), St. Michael's Hospital, University of Toronto, ON, Canada
| | - Alejandro A Rabinstein
- From the Departments of Radiology (S.G., H.K., A.M., M.A., D.F.K., R.K.), Neurologic Surgery (S.G., R.K.), and Neurology (M.L., A.A.R., D.N.), Mayo Clinic, Rochester, MN; Evidence-based Practice Center (A.S.A.), Kern Center for the Science of Healthcare Delivery, Mayo Clinic, Rochester, MN; Neuroendovascular Program (A.A.D.), Massachusetts General Hospital & Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Neurovascular Centre, Divisions of Therapeutic Neuroradiology & Neurosurgery (A.A.D.), St. Michael's Hospital, University of Toronto, ON, Canada
| | - David F Kallmes
- From the Departments of Radiology (S.G., H.K., A.M., M.A., D.F.K., R.K.), Neurologic Surgery (S.G., R.K.), and Neurology (M.L., A.A.R., D.N.), Mayo Clinic, Rochester, MN; Evidence-based Practice Center (A.S.A.), Kern Center for the Science of Healthcare Delivery, Mayo Clinic, Rochester, MN; Neuroendovascular Program (A.A.D.), Massachusetts General Hospital & Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Neurovascular Centre, Divisions of Therapeutic Neuroradiology & Neurosurgery (A.A.D.), St. Michael's Hospital, University of Toronto, ON, Canada
| | - Deena Nasr
- From the Departments of Radiology (S.G., H.K., A.M., M.A., D.F.K., R.K.), Neurologic Surgery (S.G., R.K.), and Neurology (M.L., A.A.R., D.N.), Mayo Clinic, Rochester, MN; Evidence-based Practice Center (A.S.A.), Kern Center for the Science of Healthcare Delivery, Mayo Clinic, Rochester, MN; Neuroendovascular Program (A.A.D.), Massachusetts General Hospital & Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Neurovascular Centre, Divisions of Therapeutic Neuroradiology & Neurosurgery (A.A.D.), St. Michael's Hospital, University of Toronto, ON, Canada
| |
Collapse
|
4
|
Barnea R, Agmon IN, Shafir G, Peretz S, Mendel R, Naftali J, Shiyovich A, Kornowski R, Auriel E, Hamdan A. Cardiac CT for intra-cardiac thrombus detection in embolic stroke of undetermined source (ESUS). Eur Stroke J 2022; 7:212-220. [PMID: 36082249 PMCID: PMC9446335 DOI: 10.1177/23969873221099692] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/03/2022] [Accepted: 04/22/2022] [Indexed: 10/17/2023] Open
Abstract
Introduction Embolic stroke of undetermined source (ESUS) is a common medical challenge regarding secondary prevention strategy. Cardiac imaging is the cornerstone of embolic stroke workup, in an effort to diagnose high risk cardio-embolic sources. Cardiac computed tomography angiography (CCTA) is an emerging imaging modality with high diagnostic performance for intra-cardiac thrombus detection. The yield of CCTA implementation in addition to standard care in ESUS workup is unknown. Thus, the aim of this study was to assess the utility of CCTA in detecting intra-cardiac thrombi in the routine ESUS workup. Patients and methods This is a retrospective observational analysis of ESUS cases managed in vascular neurology unit between 2019 and 2021. Within this ESUS registry, consecutive patients undergoing CCTA were included and carefully analyzed. Results During the study period 1066 Ischemic stroke (IS) cases were treated and evaluated. 266/1066 (25%) met ESUS criteria and 129/266 (48%) underwent CCTA. Intra-cardiac thrombus was detected by CCTA in 22/129 (17%; 95% CI, 11.5%-23.5%) patients: left ventricular thrombus (LVT) in 13 (10.1%) patients, left atrial appendage (LAA) thrombus in 8 (6.2%) patients, and left atrial (LA) thrombus in 1 (0.8%) patient. Only 5/22 (23%) of these thrombi were suspected, but could not be confirmed, in trans-thoracic echocardiogram (TTE). Among CCTA-undergoing patients, 27/129 (21%; 95% CI, 14%-28%) were found to have an indication (including pulmonary embolism) for commencing anticoagulation (AC) treatment, rather than anti-platelets. In favor of CCTA implementation, 22/266 (8.2%; 95% CI, 4.9%-11.5%) patients within the entire ESUS cohort were diagnosed with intra-cardiac thrombus, otherwise missed. Conclusion CCTA improves the detection of intra-cardiac thrombi in addition to standard care in ESUS patients. The implementation of CCTA in routine ESUS workup can change secondary prevention strategy in a considerable proportion of patients.
Collapse
Affiliation(s)
- Rani Barnea
- Department of Neurology, Rabin Medical
Center – Beilinson Hospital, Petach Tikva, Israel
- Sackler School of Medicine, Tel-Aviv
university, Tel-Aviv, Israel
| | - Inbar Nardi Agmon
- Sackler School of Medicine, Tel-Aviv
university, Tel-Aviv, Israel
- Department of Cardiology, Rabin Medical
Center – Beilinson Hospital, Petach Tikva, Israel
| | - Gideon Shafir
- Sackler School of Medicine, Tel-Aviv
university, Tel-Aviv, Israel
- Department of Radiology, Rabin Medical
Center – Beilinson Hospital, Petach Tikva, Israel
| | - Shlomi Peretz
- Department of Neurology, Rabin Medical
Center – Beilinson Hospital, Petach Tikva, Israel
- Sackler School of Medicine, Tel-Aviv
university, Tel-Aviv, Israel
| | - Rom Mendel
- Department of Neurology, Rabin Medical
Center – Beilinson Hospital, Petach Tikva, Israel
- Sackler School of Medicine, Tel-Aviv
university, Tel-Aviv, Israel
| | - Jonathan Naftali
- Department of Neurology, Rabin Medical
Center – Beilinson Hospital, Petach Tikva, Israel
- Sackler School of Medicine, Tel-Aviv
university, Tel-Aviv, Israel
| | - Arthur Shiyovich
- Sackler School of Medicine, Tel-Aviv
university, Tel-Aviv, Israel
- Department of Cardiology, Rabin Medical
Center – Beilinson Hospital, Petach Tikva, Israel
| | - Ran Kornowski
- Sackler School of Medicine, Tel-Aviv
university, Tel-Aviv, Israel
- Department of Cardiology, Rabin Medical
Center – Beilinson Hospital, Petach Tikva, Israel
| | - Eitan Auriel
- Department of Neurology, Rabin Medical
Center – Beilinson Hospital, Petach Tikva, Israel
- Sackler School of Medicine, Tel-Aviv
university, Tel-Aviv, Israel
| | - Ashraf Hamdan
- Sackler School of Medicine, Tel-Aviv
university, Tel-Aviv, Israel
- Department of Cardiology, Rabin Medical
Center – Beilinson Hospital, Petach Tikva, Israel
| | | |
Collapse
|
6
|
Meinel TR, Eggimann A, Brignoli K, Wustmann K, Buffle E, Meinel FG, Scheitz JF, Nolte CH, Gräni C, Fischer U, Kaesmacher J, Seiffge DJ, Seiler C, Jung S. Cardiovascular MRI Compared to Echocardiography to Identify Cardioaortic Sources of Ischemic Stroke: A Systematic Review and Meta-Analysis. Front Neurol 2021; 12:699838. [PMID: 34393979 PMCID: PMC8362907 DOI: 10.3389/fneur.2021.699838] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/24/2021] [Accepted: 06/30/2021] [Indexed: 01/21/2023] Open
Abstract
Background: To compare the diagnostic yield of echocardiography and cardiovascular MRI (CMR) to detect structural sources of embolism, in patients with ischemic stroke with a secondary analysis of non-stroke populations. Methods and Results: We searched MEDLINE/Embase (from 01.01.2000 to 24.04.2021) for studies including CMR to assess prespecified sources of embolism. Comparison included transthoracic and/or transesophageal echocardiography. Two authors independently screened studies, extracted data and assessed bias using the QUADAS-2 tool. Estimates of diagnostic yield were reported and pooled. Twenty-seven studies with 2,525 patients were included in a study-level analysis. Most studies had moderate to high risk of bias. Persistent foramen ovale, complex aortic plaques, left ventricular and left atrial thrombus were the most common pathologies. There was no difference in the yield of left ventricular thrombus detection between both modalities for stroke populations (4 studies), but an increased yield of CMR in non-stroke populations (28.1 vs. 16.0%, P < 0.001, 10 studies). The diagnostic yield in stroke patients for detection of persistent foramen ovale was lower in CMR compared to transoesophageal echocardiography (29.3 vs. 53.7%, P < 0.001, 5 studies). For both echocardiography and CMR the clinical impact of the management consequences derived from many of the diagnostic findings remained undetermined in the identified studies. Conclusions: Echocardiography and CMR seem to have similar diagnostic yield for most cardioaortic sources of embolism except persistent foramen ovale and left ventricular thrombus. Randomized controlled diagnostic trials are necessary to understand the impact on the management and potential clinical benefits of the assessment of structural cardioaortic stroke sources. Registration: PROSPERO: CRD42020158787.
Collapse
Affiliation(s)
- Thomas R Meinel
- Department of Neurology, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland
| | - Angela Eggimann
- Department of Neurology, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland
| | - Kristina Brignoli
- Department of Neurology, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland
| | - Kerstin Wustmann
- Department of Cardiology, Inselspital Bern, Bern University Hospital, and University of Bern, Bern, Switzerland
| | - Eric Buffle
- Department of Cardiology, Inselspital Bern, Bern University Hospital, and University of Bern, Bern, Switzerland
| | - Felix G Meinel
- Institute of Diagnostic and Interventional Radiology, Pediatric Radiology and Neuroradiology, Rostock University Medical Center, Rostock, Germany
| | - Jan F Scheitz
- Klinik und Hochschulambulanz für Neurologie, Charité-Universitätsmedizin Berlin, Berlin, Germany.,Klinik für Neurologie, Berlin Institute of Health, Berlin, Germany.,German Centre for Cardiovascular Research, Deutsches Zentrum für Herz-Kreislauf-Forschung, Berlin, Germany
| | - Christian H Nolte
- Klinik und Hochschulambulanz für Neurologie, Charité-Universitätsmedizin Berlin, Berlin, Germany.,Klinik für Neurologie, Berlin Institute of Health, Berlin, Germany.,German Centre for Cardiovascular Research, Deutsches Zentrum für Herz-Kreislauf-Forschung, Berlin, Germany
| | - Christoph Gräni
- Department of Cardiology, Inselspital Bern, Bern University Hospital, and University of Bern, Bern, Switzerland
| | - Urs Fischer
- Department of Neurology, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland
| | - Johannes Kaesmacher
- Institute of Diagnostic and Interventional Neuroradiology, Inselspital, Bern University Hospital, Bern, Switzerland
| | - David J Seiffge
- Department of Neurology, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland
| | - Christian Seiler
- Department of Cardiology, Inselspital Bern, Bern University Hospital, and University of Bern, Bern, Switzerland
| | - Simon Jung
- Department of Neurology, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland
| |
Collapse
|